A versatile integrated tube for rapid and visual SARS-CoV-2 detection.

Area of Science:

• Molecular Biology
• Virology
• Diagnostic Assays

Background:

• The COVID-19 pandemic necessitates rapid and widespread testing for effective control.
• Current RT-PCR methods for SARS-CoV-2 detection are laboratory-dependent and limit accessibility.
• Resource-limited settings require accessible and user-friendly diagnostic tools.

Purpose of the Study:

• To develop a rapid, convenient, and visual assay for SARS-CoV-2 detection.
• To overcome the accessibility challenges posed by traditional RT-PCR methods.
• To provide a viable alternative for widespread COVID-19 screening.

Main Methods:

• Optimization of reaction conditions using SARS-CoV-2 RNA standards.
• Determination of assay sensitivity and specificity.
• Validation of the assay on clinical specimens and comparison with RT-PCR.

Main Results:

• The integrated tube assay provides visual detection of SARS-CoV-2 within 40 minutes.
• Limits of detection (LODs) for ORF1ab and N genes were 50 copies/μl.
• The assay demonstrated 94.5% sensitivity and 100.0% specificity, with no cross-reactivity.

Conclusions:

• The developed integrated tube assay is a simple, specific, and sensitive one-pot, single-step method for SARS-CoV-2 detection.
• This assay has the potential for widespread use, particularly in resource-limited settings.
• The assay offers a valuable tool for rapid COVID-19 screening and pandemic control.